Images
Participants
![](/sites/default/files/styles/medium_220px_width/public/2021-07/GOMIS_gomis_2.jpg?itok=Su_3glcF)
Contact
![](/sites/default/files/styles/medium_220px_width/public/2020-11/nahiaprueba_0.jpg?itok=lGhKXjfl)
Various media channels have echoed the study by Roger Gomis published in the Journal of National Cancer Institute in September. The paper revealed a link between an alteracion in the MAF gene in breast cancer patients, and bone metastasis. This breakthrough may accelerate the development of the first preventive treatment for this kind of metastasis.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).